Monrovia, Liberia – The Liberia Medicines and Health Products Regulatory Authority (LMHRA), in collaboration with key stakeholders, has concluded a two-day high-level conference on Pharmacovigilance and Clinical Trials in Monrovia, bringing together health products regulators from across Africa.
The gathering focused on strengthening regulatory frameworks, improving monitoring systems for medicines and health products, and enhancing collaboration among African nations to ensure the safety and effectiveness of medical products.
Speaking at the close of the conference, LMHRA Managing Director Luke L. Bawo underscored the importance of pharmacovigilance in protecting public health and building trust in clinical trials across the continent. According to him, the meeting served as a platform to share best practices and align strategies with international standards.
Also, stakeholders, including representatives from regional regulatory bodies, health ministries, and development partners, reaffirmed their commitment to advancing Africa’s capacity to regulate medicines and oversee clinical trials.
Director Bawo narrated that the outcomes of the conference are expected to shape future regulatory cooperation and improve patient safety across the region.
After the conference, Dr. Juwe D. Kercula, the organizer, told reporters that the two-day interaction was highly productive and interactive and that the LMHRA is grateful to God for uniting regulators to accomplish a common purpose.
He said, the LMHRA plans to collaborate with a number of European regions, praising European nations for their prior assistance.
“We hope that they will build upon that even what they are seeing and listening to, challenges they will have to help with; like the average they help with in the clinical trials,” he added.
Reported by: Prince Saah
